| [1] |
Chien YW, Wang Y, Huang P, et al. Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions[J]. Am J Surg Pathol, 2024, 48(4):475-486. doi: 10.1097/PAS.0000000000002187.
|
| [2] |
Patibandla JR, Fehniger JE, Levine DA, et al. Small cell cancers of the female genital tract: Molecular and clinical aspects[J]. Gynecol Oncol, 2018, 149(2):420-427. doi: 10.1016/j.ygyno.2018.02.004.
pmid: 29458976
|
| [3] |
徐燕宁, 刘易欣, 陈凌. 卵巢高钙血症型小细胞癌的研究进展[J]. 国际妇产科学杂志, 2021, 48(5):548-552. doi: 10.12280/gjfckx.20210203.
|
| [4] |
Raupach EA, Hegde AM, Garcia-Mansfield K, et al. Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type[J]. Cancer Res, 2025, 85(14):2626-2642. doi: 10.1158/0008-5472.CAN-24-0044.
|
| [5] |
郜意, 康茗贻, 王辉, 等. 1例SMARCA4胚系变异卵巢高钙血症型小细胞癌的综合治疗和遗传咨询[J]. 中国癌症杂志, 2022, 32(11):1115-1120. doi: 10.19401/j.cnki.1007-3639.2022.11.010.
|
| [6] |
王昕颖, 汪雪雁. 卵巢遗传性疾病的防治进展与产前诊断[J]. 中国计划生育和妇产科, 2024, 16(6):14-20. doi: 10.3969/j.issn.1674-4020.2024.06.04.
|
| [7] |
Blatnik A, Dragoš VŠ, Blatnik O, et al. A Population-Based Study of Patients With Small Cell Carcinoma of the Ovary, Hypercalcemic Type, Encompassing a 30-Year Period[J]. Arch Pathol Lab Med, 2024, 148(3):299-309. doi: 10.5858/arpa.2022-0297-OA.
|
| [8] |
Tischkowitz M, Huang S, Banerjee S, et al. Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines[J]. Clin Cancer Res, 2020, 26(15):3908-3917. doi: 10.1158/1078-0432.CCR-19-3797.
pmid: 32156746
|
| [9] |
Wens F, Hulsker C, Fiocco M, et al. Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Patient Characteristics, Treatment, and Outcome-A Systematic Review[J]. Cancers(Basel), 2023, 15(15):3794. doi: 10.3390/cancers15153794.
|
| [10] |
Callegaro-Filho D, Gershenson DM, Nick AM, et al. Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases[J]. Gynecol Oncol, 2016, 140(1):53-57. doi: 10.1016/j.ygyno.2015.11.004.
pmid: 26546963
|
| [11] |
刘思萌, 靳翠翠, 邓玉辉, 等. 卵巢高钙血症型小细胞癌CT/MRI及临床特点的案例分析[J]. CT理论与应用研究, 2025, 35:1-7. doi: 10.15953/j.ctta.2024.328.
|
| [12] |
赵婧, 罗荣奎, 陈婷婷, 等. 卵巢高钙血症型小细胞癌16例临床病理学分析[J]. 中华病理学杂志, 2024, 53(12):1210-1216. doi: 10.3760/cma.j.cn112151-20240331-00213.
|
| [13] |
Hafez AAE, L-Dosoki IE, Sirag S, et al. Value of Wilms tumor gene product (WT-1) immunohistochemical expression in ovarian neoplasms[J]. Intern J Med, 2014, 2(1):22-27. doi: 10.14419/ijm.v2i1.2262.
|
| [14] |
Cyrta J, Brillet R, Laas E, et al. Additional Considerations on Aberrant BRG1 (SMARCA4) Expression in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT)[J]. Am J Surg Pathol, 2024, 48(10):1335-1338. doi: 10.1097/PAS.0000000000002296.
pmid: 39092991
|
| [15] |
王鹏, 张国文, 李贤龙, 等. 卵巢高钙血症型小细胞癌临床病理学分析及文献回顾[J]. 山西医药杂志, 2025, 54(9):651-655. doi: 10.3969/j.issn.0253-9926.2025.09.002.
|
| [16] |
何昊, 邹冬玲, 周琦, 等. 卵巢高血钙型小细胞癌误诊为颗粒细胞瘤1例教训分析[J]. 中国实用妇科与产科杂志, 2020, 36(4):380-382. doi: 10.19538/j.fk2020040121.
|
| [17] |
Ma J, Tang Y, He W, et al. Primary neuroendocrine carcinoma of the fallopian tube with exceeding 10 years follow-up: Case report and review of the literature[J]. Gynecol Oncol Rep, 2025, 58:101692. doi: 10.1016/j.gore.2025.101692.
|
| [18] |
卢淮武, 霍楚莹, 黄纯娴, 等. 《2025 NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南(第1版)》解读[J]. 中国实用妇科与产科杂志, 2025, 41(4):436-444. doi: 10.19538/j.fk2025040113.
|
| [19] |
Zheng K, Gao Y, Xu C, et al. Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis[J]. J Gynecol Oncol, 2024, 35(4):e96. doi: 10.3802/jgo.2024.35.e96.
pmid: 38710530
|
| [20] |
Jelinic P, Ricca J, Van Oudenhove E, et al. Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade[J]. J Natl Cancer Inst, 2018, 110(7):787-790. doi: 10.1093/jnci/djx277.
pmid: 29365144
|
| [21] |
周宏宇, 李浩然, 程玺, 等. 11例卵巢高钙血症型小细胞癌临床分析并文献复习[J]. 中国癌症杂志, 2021, 31(2):136-142. doi: 10.19401/j.cnki.1007-3639.2021.02.008.
|